Table 2.
Analysis | Controlled Direct Effect |
Natural Direct Effect |
Natural Indirect Effect |
Total Effect |
Proportion Mediated, % |
||||
---|---|---|---|---|---|---|---|---|---|
RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | ||
Unadjusteda | 1.13 | 1.08, 1.21 | 1.13 | 1.07, 1.20 | 1.004 | 0.999, 1.009 | 1.13 | 1.07, 1.20 | 3.27 |
Multivariable adjustedb |
|||||||||
Days since initiation | |||||||||
14 | 1.43 | 1.11, 1.81 | 1.42 | 1.10, 1.80 | 1.000 | 1.000, 1.000 | 1.42 | 1.10, 1.80 | −0.01 |
30 | 1.25 | 1.06, 1.47 | 1.25 | 1.06, 1.47 | 1.001 | 1.000, 1.003 | 1.25 | 1.07, 1.47 | 0.38 |
60 | 1.22 | 1.09, 1.36 | 1.22 | 1.10, 1.36 | 1.005 | 1.001, 1.012c | 1.23 | 1.11, 1.36 | 2.73 |
120 | 1.21 | 1.12, 1.31 | 1.21 | 1.12, 1.30 | 1.004 | 1.001, 1.012c | 1.21 | 1.13, 1.31 | 2.34 |
180 | 1.15 | 1.08, 1.22 | 1.15 | 1.08, 1.22 | 1.004 | 1.000, 1.008c | 1.15 | 1.08, 1.22 | 2.70 |
Stroke subtypea | |||||||||
Ischemic | 1.15 | 1.08, 1.22 | 1.17 | 1.08, 1.22 | 1.003 | 1.000, 1.006 | 1.15 | 1.08, 1.22 | 2.02 |
Hemorrhagic | 1.15 | 1.08, 1.22 | 1.15 | 1.08, 1.22 | 1.000 | 0.999, 1.002 | 1.15 | 1.08, 1.22 | 0.22 |
Abbreviations: CI, confidence interval; FGA, first-generation antipsychotic drug; RR, risk ratio; SGA, second-generation antipsychotic drug.
a All analyses were conducted over 180 days since initiation unless noted otherwise.
b Multivariable analyses adjusted for demographic characteristics, health services usage, comorbid chronic and psychiatric conditions, and concomitant medication use occurring before the index date, as listed in Web Table 1.
c The lower confidence bound for indirect effect is above the null.